Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CMPS compared with IMCR: revenue, margins and what each company keeps, and the suppliers and customers both name
CMPS
COMPASS Pathways plc
Change
Mkt cap
Revenue
Revenue
IMCR
Immunocore Holdings plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
CMPS
COMPASS Pathways plc
vs
IMCR
Immunocore Holdings plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CMPS
0
None
Shared
0
No disclosed counterparties: CMPS.
Only IMCR
1
—
Adaptimmune Therapeutics
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CMPS
COMPASS Pathways plc
Change
8.35
▲
+6.97%
Mkt cap
$1.2B
Revenue
—
Revenue
—
IMCR
Immunocore Holdings plc
Change
29.78
▲
+4.87%
Regular session
Nov 6 '26
Mkt cap
$1.5B
Revenue
$102M
Q3 FY26
Revenue
$400M
FY25
vs
Compare
Regular session
Nov 6 '26
CMPS
COMPASS Pathways plc
vs
IMCR
Immunocore Holdings plc
8.35
▲
+6.97%
Price
29.78
▲
+4.87%
$1.2B
Mkt cap
$1.5B
—
Revenue
$102M
Q3 FY26
—
Revenue
$400M
FY25
Change
Change
CMPS
8.35
▲
+6.97%
vs
IMCR
29.78
▲
+4.87%
Regular session
Nov 6 '26